| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,600 | 5,000 | 10:40 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.09. | Elekta AB: New phase 2 data show favorable cognitive outcomes with Leksell Gamma Knife in patients with up to 50 brain metastases | 139 | GlobeNewswire (Europe) | BOSTON - Elekta (EKTA-B.ST) today announced new phase 2 data, presented at ASTRO by lead investigator Dr. Chia-Lin Tseng, demonstrating favorable cognitive outcomes with Leksell Gamma Knife® radiosurgery... ► Artikel lesen | |
| 28.09. | Elekta AB: Study presented at ASTRO shows promising long-term outcomes for patients with localized pancreatic cancer treated on Elekta Unity | 245 | GlobeNewswire (Europe) | New data underscore the potential of MR-guided adaptive radiotherapy as Elekta advances Elekta Unity with Unity Pro to help bring adaptive treatment to more centers.
BOSTON - Elekta (EKTA-B.ST) highlights... ► Artikel lesen | |
| 27.09. | Elekta AB: Elekta expands adaptive workflows across its radiotherapy portfolio | 296 | GlobeNewswire (Europe) | New capabilities across CT, MR, radiosurgery and brachytherapy give centers more ways to bring adaptive treatment into everyday clinical practice.
BOSTON - Elekta (EKTA-B.ST) today announced the expansion... ► Artikel lesen | |
| 03.09. | Elekta AB: Report from the Annual General Meeting 2026 of Elekta | 340 | GlobeNewswire (Europe) | Elekta AB (publ) has held its Annual General Meeting on September 3, 2026. The statement at the Meeting from the CEO and President will be available on Elekta's website, www.elekta.com. Documents from... ► Artikel lesen | |
| 27.08. | Elekta Q1 FY27 slides: margins surge but revenue growth lags market | 3 | Investing.com | ||
| 27.08. | Earnings Call: Elekta steigert in Q1 2026 die Marge, doch Aktie fällt um 5,6 % | 2 | Investing.com Deutsch | ||
| 27.08. | Elekta AB Non-GAAP EPS of SEK 0.69, revenue of SEK 3.54B; reaffirms full-year outlook | 1 | Seeking Alpha | ||
| 27.08. | Schwache Profitabilität schickt Elekta Aktie auf Talfahrt | 1 | Investing.com Deutsch | ||
| ELEKTA AB ADR Aktie jetzt für 0€ handeln | |||||
| 27.08. | Elekta AB Ser. B Bottom Line Rises In Q1 | 2 | RTTNews | ||
| 27.08. | Elekta AB: First quarter, May-July 2026/27 | 269 | GlobeNewswire (Europe) | First quarterRegions Americas and Europe showed solid growth while region APJ, China and TIMEA declined. In constant exchange rates, net sales decreased by 2 percent for the Group. Reported sales in... ► Artikel lesen | |
| 17.06. | Elekta Aktie unter Druck: Kapitalmarkttag enttäuscht Anleger | 17 | Investing.com Deutsch | ||
| 17.06. | Elekta AB: Elekta presents financial targets and detailed outlook ahead of Capital Markets Day | 833 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) today presents new mid-term financial targets and a more detailed outlook for fiscal year (FY) 2026/2027 ahead of its Capital Markets Day in Stockholm.
Elekta is planning... ► Artikel lesen | |
| 28.05. | Elekta-Aktie bricht nach gemischten Q4-Zahlen um 14 % ein | 27 | Investing.com Deutsch | ||
| 28.05. | Elekta Non-GAAP EPS of SEK 0.57, revenue of SEK 4.76B; gives fiscal year 2026/27 outlook | 5 | Seeking Alpha | ||
| 28.05. | Elekta AB: Year-end report May-April 2025/26 | 730 | GlobeNewswire (Europe) | Fourth quarterIn constant exchange rates, net sales decreased by 1 percent mainly driven by APAC, despite growth in China. Reported sales in SEK decreased by 8 percent amounting to SEK 4,762 M (5,156).Fourth... ► Artikel lesen | |
| 06.03. | Dividendenbekanntmachungen (06.03.2026) | 11.816 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUSHNET HOLDINGS CORP US0050981085 0,255 USD 0,2196 EUR AMERIGO RESOURCES LTD CA03074G1090 0,04 CAD 0,0251 EUR AMPOL LIMITED AU0000088338 0... ► Artikel lesen | |
| 05.03. | Elekta AB: Third quarter, November-January 2025/26 | 410 | GlobeNewswire (Europe) | Third quarterIn constant exchange rates, net sales increased by 2 percent mainly driven by Europe and China. Reported sales in SEK decreased by 10 percent amounting to SEK 4,239 M (4,695).The book-to-bill... ► Artikel lesen | |
| 30.01. | Elekta AB: Elekta presents Strategic Update: growth, innovation, and operations | 821 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) today, at 14:00 CET, hosts its Strategic Update for investors, providing an overview of the company's strategic direction and ongoing transformation. The event, led by... ► Artikel lesen | |
| 26.11.25 | Elekta AB: Second quarter, August-October 2025/26 | 641 | GlobeNewswire (Europe) | Second quarterIn constant exchange rates, net sales increased by 1 percent mainly driven by Europe. Reported sales in SEK decreased by 6 percent amounting to SEK 4,070 M (4,341).The book-to-bill ratio... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,034 | +1,99 % | Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform | ||
| STRAUMANN | 94,52 | +0,08 % | Bis zu 60% Kurschance: Goldman baut seine Europa-Favoriten um: Das sind die neuen Top-Picks | © Foto: Thomas Trutschel - Photothek Media LabGoldman Sachs mischt seine europäischen Aktien-Favoriten neu: Solaria, Straumann, Scout24 und IMCD steigen auf. Beim deutschen Immobilienportal sehen die... ► Artikel lesen | |
| FAMICORD | 2,970 | -2,30 % | EQS-News: FamiCord AG gewinnt vielversprechenden CDMO-Neukunden mit Herstellungsvereinbarung für zulassungsrelevante Phase-II/III-Studie bei anfänglichem Volumen im niedrigen einstelligen Millionen-Euro-Bereich | EQS-News: FamiCord AG
/ Schlagwort(e): Vertrag
FamiCord AG gewinnt vielversprechenden CDMO-Neukunden mit Herstellungsvereinbarung für zulassungsrelevante Phase-II/III-Studie bei... ► Artikel lesen | |
| CARDINAL HEALTH | 212,80 | -0,19 % | Reasons to Retain Cardinal Health Stock in Your Portfolio for Now | ||
| DAVITA | 157,70 | +0,19 % | DaVita Community Care Report 2025: Empowering Teammates Through Career Development and Education | Paving Career Paths to Economic Mobility NORTHAMPTON, MA / ACCESS Newswire / September 14, 2026 / Sustainable career growth is about unlocking lasting economic mobility and new opportunities to learn... ► Artikel lesen | |
| SPINEWAY | 0,104 | 0,00 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,670 | 0,00 % | Ping An Healthcare and Technology Company Limited: From Advice to Action: How Ping An Good Doctor Is Bringing Healthcare AI into the Real World | HONG KONG, Sept. 23, 2026 /PRNewswire/ -- Most healthcare AI tools can analyze symptoms and suggest a care plan, but far fewer can help patients follow through. The gap appears both when people... ► Artikel lesen | |
| DENTSPLY SIRONA | 7,848 | +1,42 % | DENTSPLY SIRONA Inc.: Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity Urinary Management Portfolio | Traditional Medicare reimbursement supports broader access to non-invasive management options for eligible beneficiaries living with permanent urinary incontinence MÖLNDAL, Sweden, Oct. 07, 2026... ► Artikel lesen | |
| PETMED EXPRESS | 1,138 | +0,09 % | PetMed Express, Inc.: PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| MOLINA HEALTHCARE | 173,20 | -0,80 % | $1000 Invested In Molina Healthcare 15 Years Ago Would Be Worth This Much Today | ||
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | William Blair stuft Alignment Healthcare wegen Kostendruck und Rating-Herabstufung ab | ||
| HEARTFLOW | 47,590 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen |